Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background/Aims: This study evaluated the clinical outcomes of balloon-occluded retrograde transvenous obliteration (BRTO) for the treatment of hemorrhage from gastric varices (GV) in Korean patients with liver cirrhosis (LC). Methods: We retrospectively analyzed data from 183 LC patients who underwent BRTO for GV bleeding in 6 universitybased hospitals between January 2001 and December 2010. Results: Of the 183 enrolled patients, 49 patients had Child-Pugh (CP) class A LC, 105 had CP class B, and 30 had CP class C at the time of BRTO. BRTO was successfully performed in 177 patients (96.7%). Procedure-related complications (e.g., pulmonary thromboembolism and renal infarction) occurred in eight patients (4.4%). Among 151 patients who underwent follow-up examinations of GV, 79 patients (52.3%) achieved eradication of GV, and 110 patients (72.8%) exhibited marked shrinkage of the treated GV to grade 0 or I. Meanwhile, new-appearance or aggravation of esophageal varices (EV) occurred in 54 out of 136 patients who underwent follow-up endoscopy (41.2%). During the 36.0±29.2 months (mean±SD) of follow-up, 39 patients rebled (hemorrhage from GV in 7, EV in 18, nonvariceal origin in 4, and unknown in 10 patients). The estimated 3-year rebleeding-free rate was 74.8%, and multivariate analysis showed that CP class C was associated with rebleeding (odds ratio, 2.404; 95% confidence-interval, 1.013-5.704; P=0.047). Conclusions: BRTO can be performed safely and effectively for the treatment of GV bleeding. However, aggravation of EV or bleeding from EV is not uncommon after BRTO; thus, periodic endoscopy to follow-up of EV with or without prophylactic treatment might be necessary in LC patients undergoing BRTO. (Clin Mol Hepatol 2012;18:368-374)
Abstract
Background/Aims: This study evaluated the clinical outcomes of balloon-occluded retrograde transvenous obliteration (BRTO) for the treatment of hemorrhage from gastric varices (GV) in Korean patients with liver cirrhosis (LC). Methods: We retrospectively analyzed data from 183 LC patients who underwent BRTO for GV bleeding in 6 universitybased hospitals between January 2001 and December 2010. Results: Of the 183 enrolled patients, 49 patients had Child-Pugh (CP) class A LC, 105 had CP class B, and 30 had CP class C at the time of BRTO. BRTO was successfully performed in 177 patients (96.7%). Procedure-related complications (e.g., pulmonary thromboembolism and renal infarction) occurred in eight patients (4.4%). Among 151 patients who underwent follow-up examinations of GV, 79 patients (52.3%) achieved eradication of GV, and 110 patients (72.8%) exhibited marked shrinkage of the treated GV to grade 0 or I. Meanwhile, new-appearance or aggravation of esophageal varices (EV) occurred in 54 out of 136 patients who underwent follow-up endoscopy (41.2%). During the 36.0±29.2 months (mean±SD) of follow-up, 39 patients rebled (hemorrhage from GV in 7, EV in 18, nonvariceal origin in 4, and unknown in 10 patients). The estimated 3-year rebleeding-free rate was 74.8%, and multivariate analysis showed that CP class C was associated with rebleeding (odds ratio, 2.404; 95% confidence-interval, 1.013-5.704; P=0.047). Conclusions: BRTO can be performed safely and effectively for the treatment of GV bleeding. However, aggravation of EV or bleeding from EV is not uncommon after BRTO; thus, periodic endoscopy to follow-up of EV with or without prophylactic treatment might be necessary in LC patients undergoing BRTO. (Clin Mol Hepatol 2012;18:368-374)
참고문헌 (26)
- Sarin SK, "Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
- Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)
- Sarin SK, "Endoscopic sclerotherapy in the treatment of gastric varices", Br J Surg, 75, pp.747~750 (1988)
- Sanyal AJ, "The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts", Gastroenterology, 112, pp.889~898 (1997)
- Idezuki Y, "Present status of sclerotherapy and surgical treatment for esophageal varices in Japan. Japanese Research Society for Portal Hypertension and Japanese Research Society for Sclerotherapy of Esophageal Varices", World J Surg, 16, pp.1193~1200 (1992)
- Kanagawa H, "Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration", J Gastroenterol Hepatol, 11, pp.51~58 (1996)
- Kumamoto M, "Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome", J Gastroenterol Hepatol, 25, pp.1129~1135 (2010)
- Akahoshi T, "Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience", J Gastroenterol Hepatol, 23, pp.1702~1709 (2008)
- Hiraga N, "The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration", J Gastroenterol, 42, pp.663~672 (2007)
- Ninoi T, "Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients", AJR Am J Roentgenol, 184, pp.1340~1346 (2005)
- Miyamoto Y, "Balloonoccluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension", J Gastroenterol Hepatol, 18, pp.934~942 (2003)
- Fukuda T, "Long-term results of balloonoccluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy", J Vasc Interv Radiol, 12, pp.327~336 (2001)
- Kawanaka H, "Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration", Am J Gastroenterol, 90, pp.508~510 (1995)
- Cho SK, "Balloonoccluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients", AJR Am J Roentgenol, 189, pp.W365~W372 (2007)
- YoungHoChoi, "Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding:Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt", Korean Journal of Radiology, 4(2), pp.6~116 (2003), 대한영상의학회
- Choi YS, "Effect of balloon-occluded retrograde transvenous obliteration on the natural history of coexisting esophageal varices", J Clin Gastroenterol, 42, pp.974~979 (2008)
- Park SJ, "The Prevalence, Risk Factors, and Clinical Outcome of Balloon Rupture in Balloon-occluded Retrograde Transvenous Obliteration of Gastric Varices", JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 21(4), pp.503~507 (2010), ELSEVIER SCIENCE INC
- Sarin SK, "Gastric varices: profile, classification, and management", Am J Gastroenterol, 84, pp.1244~1249 (1989)
- Hashizume M, "Endoscopic classification of gastric varices", Gastrointest Endosc, 36, pp.276~280 (1990)
- Zoli M, "Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis", Hepatology, 24, pp.1047~1052 (1996)
- Garcia-Tsao G, "Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Hepatology, 46, pp.922~938 (2007)
- de Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 53, pp.762~768 (2010)
- Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis.", The Korean journal of hepatology, 18(1), pp.1~21 (2012), Korean Association for the Study of the Liver
- Akahane T, "Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration", Am J Gastroenterol, 92, pp.1026~1030 (1997)
- Uehara H, "Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient", J Gastroenterol Hepatol, 27, pp.137~141 (2012)
- Kato T, "Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis", Intern Med, 40, pp.688~691 (2001)